NEW ARC HBR DEFINITION
June 20,2019 | News | BioFreedom
For 7 years, we have been providing solutions to study and treat HBR patients.
Biosensors is proud to have contributed to increase the awareness of HBR patients who require an individualized treatment.
Now, a new ARC HBR definition will continue to improve the care of these patients.
NEW: A BETTER OPTION FOR YOUR HIGH BLEEDING RISK PATIENTS?
October 2, 2019 | News | BioFreedom
BioFreedom™ leads the way with data in HBR patients with >3,000 patients studied and safety and efficacy at 2 year follow up, with one month ultra-short DAPT and >300,000 real world implants.